BRCA2 and ovarian cancer: According to previously published results, this mutation accounts for 31% of the BRCA1 and BRCA2 mutations identified in Greek familial breast/ovarian cancer patients (Ladopoulou et al, 2002; Konstantopoulou et al, 2008).